Results 11 to 20 of about 4,927 (252)

Sustained Control of Serpiginous Choroiditis with the Fluocinolone Acetonide 0.18 mg Intravitreal Implant [PDF]

open access: yesCase Reports in Ophthalmological Medicine, 2022
Purpose. To describe an alternative treatment for a patient with serpiginous choroiditis (SC) who was not tolerant to systemic therapies. Methods. Case report of a patient with serpiginous choroiditis with their clinical course followed with ophthalmic ...
Yousuf Siddiqui   +4 more
doaj   +2 more sources

Classical versus chemometrics tools for spectrophotometric determination of fluocinolone acetonide, ciprofloxacin HCl and ciprofloxacin impurity-A in their ternary mixture [PDF]

open access: yesBMC Chemistry, 2023
Green, simple, accurate and robust univariate and chemometrics assisted UV spectrophotometric approaches have been adopted and validated for concurrent quantification of fluocinolone acetonide (FLU), ciprofloxacin HCl (CIP) together with ciprofloxacin ...
Mahmoud A. Tantawy   +3 more
doaj   +2 more sources

Intraocular Pressure Changes After Intravitreal Fluocinolone Acetonide Implant: Results from Four European Countries [PDF]

open access: yesOphthalmol Ther, 2022
none14siIntroduction: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant delivers a continuous intravitreal corticosteroid dose for the treatment of refractory diabetic macular oedema (DMO). The aim of this study was to assess the impact of an
Arnould, Louis   +13 more
core   +3 more sources

Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report [PDF]

open access: yesCase Reports in Ophthalmology, 2022
Diabetic macular edema (DME) is now a well-known condition for which a number of treatments have been shown to be effective. Intraocular corticosteroids are part of this therapeutic arsenal but are sometimes responsible for ocular hypertension.
Amina Rezkallah   +5 more
doaj   +2 more sources

Intravitreal Fluocinolone Acetonide 0.19 mg Implant in a Patient with Resistant Blau Syndrome: A Case Report [PDF]

open access: yesCase Reports in Ophthalmology
Introduction: Blau syndrome is a progressive disease with an unknown etiology and pathogenesis. It can cause severe damage, especially in the eye with severe involvement.
Khushi Saigal, Arash Maleki
doaj   +2 more sources

Long-Acting Fluocinolone Acetonide Intravitreal Implant for Recurrent Bilateral Non-Infectious Posterior Uveitis [PDF]

open access: yesInternational Medical Case Reports Journal, 2022
Adrian T Babel,1,2 Eric K Chin,3,4 David RP Almeida2 1Boonshoft School of Medicine, Dayton, OH, USA; 2Erie Retinal Surgery, Erie, PA, USA; 3Retina Consultants of Southern California, Redlands, CA, USA; 4Loma Linda Eye Institute, Veterans Affair Hospital,
Babel AT, Chin EK, Almeida DRP
doaj   +2 more sources

Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Non-Infectious Uveitis [PDF]

open access: goldJ Clin Med, 2021
Muaas Hikal   +5 more
openalex   +2 more sources

Mass spectrometry in ocular drug research

open access: yesMass Spectrometry Reviews, EarlyView., 2023
Abstract Mass spectrometry (MS) has been proven as an excellent tool in ocular drug research allowing analyzes from small samples and low concentrations. This review begins with a short introduction to eye physiology and ocular pharmacokinetics and the relevance of advancing ophthalmic treatments.
Eva M. del Amo   +6 more
wiley   +1 more source

Synthesis and RP-TLC lipophilicity evaluation of a novel fluocinolon acetonide soft drug derivative [PDF]

open access: yesKragujevac Journal of Science, 2016
Cortienic acid was obtained by periodic acid oxidation of fluocinolone acetonide, whereas corresponding amide was synthesized from the cortienic acid and ethyl ester of b-alanine by dicyclohexylcarbodiimide - hydroxybenzotriazole coupling procedure ...
Dobričić Vladimir   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy